Artificial intelligence is changing regulatory affairs, but success requires more than automation. This white paper examines how AI helps life sciences organizations improve regulatory strategy, strengthen submission quality, navigate global compliance requirements, and accelerate patient access to innovative therapies. Learn how regulatory teams can leverage AI-driven decision support, regulatory intelligence, and institutional knowledge to improve market access, reduce regulatory complexity, and ultimately drive better patient outcomes.